Novartis Investigator Site

Omaha, Nebraska 68198-5885

0 studies enrolling now · 9 studies all time

What they study most

Asthma, Chronic Obstructive Pulmonary Disease, Chronic Obstructive Pulmonary Disease (COPD), Rheumatoid Arthritis

Studies at this site

• Long-term Efficacy, Safety and Tolerability of ACZ885 in Patients With Rheumatoid Arthritis — Completed
• Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma — Completed
• 1-year Study to Assess the Efficacy, Safety, and Tolerability of Glycopyrronium Bromide (NVA237) in Chronic Obstructive Pulmonary Disease (COPD) — Completed
• Safety of Indacaterol in Patients (≥ 12 Years) With Moderate to Severe Persistent Asthma — Completed
• Comparison of Efficacy of Indacaterol Versus Placebo Over 12 Weeks — Completed
• 12-week Efficacy of Indacaterol — Completed
• Efficacy and Safety of Different Doses of Indacaterol in Chronic Obstructive Pulmonary Disease (COPD) — Completed
• Safety and Efficacy of Indacaterol Once Daily Versus Salmeterol Twice Daily in Chronic Obstructive Pulmonary Disease (COPD) — Completed
• Safety and Efficacy of Multiple Doses of Canakinumab (ACZ885) in Chronic Obstructive Pulmonary Disease (COPD) Patients — Completed